Latest publications

Definition of Clinically Meaningful Within-Patient Changes in POEM and CDLQI in Children 6 to 11 Years of Age with Severe Atopic Dermatitis. Simpson EL, De Bruin-Weller M, Bansal A, Chen Z, Nelson L, Whalley D et al. Dermatol Ther (Heidelb) 2021 May 27

Predicting recurrence in patients with sentinel node-negative melanoma: validation of the EORTC nomogram using population-based data. El Sharouni MA, Ahmed T, Witkamp AJ, Sigurdsson V, Van Gils CH, Nieweg OE et al. Br J Surg 2021 May 27; 108(5):550-553

Dupilumab Provides Significant Clinical Benefit in a Phase 3 Trial in Adolescents with Uncontrolled Atopic Dermatitis Irrespective of Prior Systemic Immunosuppressant Use. Deleuran M, Marcoux D, De Bruin-Weller MS, Irvine AD, Baselga E, Ahn K et al. Acta Derm Venereol 2021 May 27

Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial. Reich K, Teixeira HD, De Bruin-Weller M, Bieber T, Soong W, Kabashima K et al. Lancet 2021 Jun 05; 397(10290):2169-2181

Comparison of Two Strategies to Generate Antigen-Specific Human Monoclonal Antibodies: Which Method to Choose for Which Purpose? Ehlers AM, Den Hartog Jager CF, Kardol-Hoefnagel T, Katsburg MMD, Knulst AC, Otten HG et al. Front Immunol 2021; 12:660037

Distinction between peanut allergy and tolerance by characterization of B​ cell receptor repertoires. Ehlers AM, Den Hartog Jager CF, Knulst AC, Otten HG et al. Allergy 2021 May 10

Cuperus E, Sigurdsson V, Van den Akker PC, Bolling MC, Van Gijn ME, Pasmans SGMA et al. J Dtsch Dermatol Ges 2021 Apr; 19(4):611-614

Nomenclature and clinical phenotypes of atopic dermatitis. Girolomoni G, De Bruin-Weller M, Aoki V, Kabashima K, Deleuran M, Puig L et al. Ther Adv Chronic Dis 2021; 12:20406223211002979

High discordance rate in assessing sentinel node positivity in cutaneous melanoma: Expert review may reduce unjustified adjuvant treatment. El Sharouni MA, Laeijendecker AE, Suijkerbuijk KP, Witkamp AJ, Sigurdsson V, Van Diest PJ et al. Eur J Cancer 2021 May; 149:105-113

Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts. Ring J, Worm M, Wollenberg A, Thyssen JP, Jakob T, Klimek L et al. J Eur Acad Dermatol Venereol 2021 Jun; 35(6):e362-e365

Fructo-Oligosaccharides Modify Human DC Maturation and Peanut-Induced Autologous T-Cell Response of Allergic Patients . Hayen SM, Knulst AC, Garssen J, Otten HG, Willemsen LEM et al. Front Immunol 2020; 11:600125

Predicting sentinel node positivity in patients with melanoma: external validation of a risk-prediction calculator (the Melanoma Institute Australia nomogram) using a large European population-based patient cohort. El Sharouni MA, Varey AHR, Witkamp AJ, Ahmed T, Sigurdsson V, Van Diest PJ et al. Br J Dermatol 2021 Mar 03

Early and Long-Term Effects of Dupilumab Treatment on Circulating T-Cell Functions in Patients with Moderate-to-Severe Atopic Dermatitis. Bakker DS, Van der Wal MM, Heeb LEM, Giovannone B, Asamoah M, Delemarre EM et al. J Invest Dermatol 2021 Feb 18

Development and Validation of Nomograms to Predict Local, Regional, and Distant Recurrence in Patients With Thin (T1) Melanomas. El Sharouni MA, Ahmed T, Varey AHR, Elias SG, Witkamp AJ, Sigurdsson V et al. J Clin Oncol 2021 Apr 10; 39(11):1243-1252

European Task Force on Atopic Dermatitis: position on vaccination of adult patients with atopic dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologics. Thyssen JP, Vestergaard C, Barbarot S, De Bruin-Weller MS, Bieber T, Taieb A et al. J Eur Acad Dermatol Venereol 2021 May; 35(5):e308-e311